Nyla A. Heerema

1985–2025 年に発表

148
論文数
34,115
被引用数
98
h 指数
146
i10 指数

被引用数

Nyla A. Heerema の年別被引用数1986 年: 被引用 3 件1987 年: 被引用 4 件1988 年: 被引用 2 件1989 年: 被引用 3 件1990 年: 被引用 12 件1991 年: 被引用 12 件1992 年: 被引用 3 件1993 年: 被引用 9 件1994 年: 被引用 9 件1995 年: 被引用 3 件1996 年: 被引用 1 件1997 年: 被引用 20 件1998 年: 被引用 33 件1999 年: 被引用 32 件2000 年: 被引用 67 件2001 年: 被引用 32 件2002 年: 被引用 60 件2003 年: 被引用 59 件2004 年: 被引用 62 件2005 年: 被引用 75 件2006 年: 被引用 105 件2007 年: 被引用 145 件2008 年: 被引用 189 件2009 年: 被引用 218 件2010 年: 被引用 281 件2011 年: 被引用 225 件2012 年: 被引用 292 件2013 年: 被引用 261 件2014 年: 被引用 319 件2015 年: 被引用 449 件2016 年: 被引用 322 件2017 年: 被引用 344 件2018 年: 被引用 344 件2019 年: 被引用 1,125 件2020 年: 被引用 1,140 件2021 年: 被引用 1,170 件2022 年: 被引用 741 件2023 年: 被引用 554 件2024 年: 被引用 856 件2025 年: 被引用 336 件2026 年: 被引用 8 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,544 件、この内訳の 30.1%ドイツ: 引用元論文 851 件、この内訳の 7.2%イギリス: 引用元論文 793 件、この内訳の 6.7%イタリア: 引用元論文 652 件、この内訳の 5.5%中国: 引用元論文 645 件、この内訳の 5.5%フランス: 引用元論文 485 件、この内訳の 4.1%オランダ: 引用元論文 406 件、この内訳の 3.4%カナダ: 引用元論文 405 件、この内訳の 3.4%オーストラリア: 引用元論文 364 件、この内訳の 3.1%スペイン: 引用元論文 330 件、この内訳の 2.8%スイス: 引用元論文 241 件、この内訳の 2.1%日本: 引用元論文 221 件、この内訳の 1.9%
0%30.1%その他 24.2%

分野

  • Medicine74.2%
  • Biochemistry, Genetics and Molecular Biology20.2%
  • Immunology and Microbiology3%
  • Agricultural and Biological Sciences0.7%
  • Chemistry0.5%
  • Computer Science0.3%
  • その他1.1%

トピック

  • Acute Lymphoblastic Leukemia research10.7%
  • Chronic Lymphocytic Leukemia Research8.5%
  • Acute Myeloid Leukemia Research8.4%
  • Lymphoma Diagnosis and Treatment6.4%
  • Chronic Myeloid Leukemia Treatments5.2%
  • Childhood Cancer Survivors' Quality of Life4.1%
  • その他56.7%

共著者

全論文

検索で開く
  1. The genomic landscape of pediatric acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott G. Foy, Dale J. Hedges, Scott Newman, Xin Zhou, Jian Wang, Colleen Reilly, Edgar Sioson, Stephen V. Rice, Victor Pastor Loyola, Gang Wu, Evadnie Rampersaud, Shalini C. Reshmi, Julie M. Gastier-Foster, Jaime M. Guidry Auvil, Patee Gesuwan, Malcolm A. Smith, Naomi Winick, Andrew J. Carroll, Nyla A. Heerema, Richard C. Harvey, Cheryl L. Willman, Eric Larsen, Elizabeth A. Raetz, Michael J. Borowitz, Brent L. Wood, William L. Carroll, Patrick A. Zweidler‐McKay, Karen R. Rabin, Leonard A. Mattano, Kelly W. Maloney, Stuart S. Winter, Michael J. Burke, Wanda L. Salzer, Kimberly P. Dunsmore, Anne Angiolillo, Kristine R. Crews, James R. Downing, Sima Jeha, Ching‐Hon Pui, William E. Evans, Jun J. Yang, Mary V. Relling, Daniela S. Gerhard, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan - Nature Genetics 2022 被引用: 397

  2. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kimberly P. Dunsmore, Stuart S. Winter, Brent L. Wood, Brian P. Sorrentino, James R. Downing, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan - Nature Genetics 2017 被引用: 934

  3. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John C. Byrd - New England Journal of Medicine 2018 被引用: 952

  4. Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 2,249

  5. Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Panduka Nagahawatte, Gang Wu, Xiang Chen, Donald Yergeau, Bhavin Vadodaria, Heather L. Mulder, Naomi Winick, Eric Larsen, William L. Carroll, Nyla A. Heerema, Andrew J. Carroll, Guy H. Grayson, Sarah K. Tasian, Andrew S. Moore, Frank Keller, Melissa Frei‐Jones, James A. Whitlock, Elizabeth A. Raetz, Deborah L. White, Timothy P. Hughes, Jaime M. Guidry Auvil, Malcolm A. Smith, Guido Marcucci, Clara D. Bloomfield, Krzysztof Mrózek, Jessica Kohlschmidt, Wendy Stock, Steven M. Kornblau, Marina Konopleva, Elisabeth Paietta, Ching‐Hon Pui, Sima Jeha, Mary V. Relling, William E. Evans, Daniela S. Gerhard, Julie M. Gastier-Foster, Elaine R. Mardis, Richard K. Wilson, Mignon L. Loh, James R. Downing, Stephen P. Hunger, Cheryl L. Willman, Jinghui Zhang, Charles G. Mullighan - New England Journal of Medicine 2014 被引用: 1,376

  6. BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy J. Johnson, John C. Byrd - Journal of Clinical Oncology 2017 被引用: 471

  7. The genetic basis and cell of origin of mixed phenotype acute leukaemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brent L. Wood, Nyla A. Heerema, Andrew Carrol, Yung‐Li Yang, Malcolm A. Smith, Tanja M. Davidsen, Leandro C. Hermida, Patee Gesuwan, Marco A. Marra, Yussanne Ma, Andrew J. Mungall, Richard A. Moore, Steven J.M. Jones, Marcus B. Valentine, Laura J. Janke, Jeffrey E. Rubnitz, Ching‐Hon Pui, Liang Ding, Yu Liu, Jinghui Zhang, Kim E. Nichols, James R. Downing, Xueyuan Cao, Lei Shi, Stanley Pounds, Scott Newman, Deqing Pei, Jaime M. Guidry Auvil, Daniela S. Gerhard, Stephen P. Hunger, Hiroto Inaba, Charles G. Mullighan - Nature 2018 被引用: 374

  8. Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2015 被引用: 576

  9. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Vietz, Eric A. Severson, Molly Miller, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy F. Chen, Mona Stefanos, Brian Druker, John C. Byrd - Nature Medicine 2020 被引用: 192

  10. Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

    著者: , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 183

  11. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0331

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 198

  12. The genomic landscape of hypodiploid acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charles Lu, Robert S. Fulton, Lucinda Fulton, Yashodhan Tabib, David J. Dooling, Kerri Ochoa, Mark D. Minden, Ian D. Lewis, L.B. To, Paula Marlton, Andrew W. Roberts, Gordana Raca, Wendy Stock, Geoffrey Neale, Hans G. Drexler, Ross A. Dickins, David W. Ellison, Sheila Shurtleff, Ching‐Hon Pui, Raul C. Ribeiro, Meenakshi Devidas, Andrew J. Carroll, Nyla A. Heerema, Brent L. Wood, Michael J. Borowitz, Julie M. Gastier‐Foster, Susana C. Raimondi, Elaine R. Mardis, Richard K. Wilson, James R. Downing, Stephen P. Hunger, Mignon L. Loh, Charles G. Mullighan - Nature Genetics 2013 被引用: 728

  13. Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 255

  14. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 380

  15. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Webb, Zuzana Zemanová, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink - Blood 2009 被引用: 447

  16. Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 104

  17. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children’s Oncology Group AALL0434 Methotrexate Randomization

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 237

  18. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice

    著者: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 被引用: 943

  19. Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib

    著者: , , , , , , , , , , , , , , , - Blood 2015 被引用: 656

  20. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

    著者: , , , , , , , , , , , , , , , , , , , - Leukemia 2014 被引用: 449

  21. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Van Loo, Michael R. Stratton, Peter J. Campbell, Christine J. Harrison - Nature 2014 被引用: 286

  22. Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 250

  23. Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

    著者: , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2017 被引用: 162

  24. Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 101